raghavendra_s
★    

2010-02-27 05:31
(5952 d 00:28 ago)

Posting: # 4829
Views: 7,204
 

 IP accountability [GxP / QC / QA]

Dear Sir,

In a BA/BE study if the query for Investigational products is not resolved on the check-in day or say if it is delayed and get resolved on the dosing day early morning, can the IP accountability and identification can be done or we should wait for the sponsor's response?

Thanks in advance,
Ohlbe
★★★

France,
2010-02-27 13:45
(5951 d 16:14 ago)

@ raghavendra_s
Posting: # 4831
Views: 5,850
 

 IP accountability

Dear Raghavendra,

❝ Dear Sir,


We also have some Ladies on the forum. Don't discourage them from answering.

❝ In a BA/BE study if the query for Investigational products is not resolved


❝ we should wait for the sponsor's response?


What query ? What response ? Sorry but I just don't understand what you're talking about.

Regards
Ohlbe

Regards
Ohlbe
raghavendra_s
★    

2010-03-01 08:15
(5949 d 21:44 ago)

(edited on 2010-03-01 11:49)
@ Ohlbe
Posting: # 4837
Views: 5,833
 

 IP accountability

Dear Madam/Sir,

Say any query related to IP which might supposed to be answered by sponsor only. Then what further action we may require to move-forward ?

Kind regards,



Edit: Full quote removed. Please delete anything from the text of the original poster which is not necessary in understanding your answer; see also this post! [Jaime]
Ohlbe
★★★

France,
2010-03-01 13:07
(5949 d 16:52 ago)

@ raghavendra_s
Posting: # 4838
Views: 5,969
 

 IP accountability

Dear Raghavendra,

Once again it depends on the question...

If the answer is absolutely needed before you can administer the product to the subjects (for instance the expiry date), then telling the sponsor no answer would result in postponing the trial usually helps to get a fast answer.

Whether you can already dispense/package the IMP depends on its primary packaging and on how you do the packaging yourself, I would say. If it is in a large bottle, or if you remove it from its blister: this is usually done on the day before dosing, for stability reasons. So if you're not sure to be able to dose, doing the dispensing/packaging may be a problem. If the IMP remains in its blister, then no problem to do the dispensing/packaging in advance.

Regards
Ohlbe

Regards
Ohlbe
UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,570 registered users;
121 visitors (0 registered, 121 guests [including 18 identified bots]).
Forum time: 07:00 CEST (Europe/Vienna)

The idea is to try and give all the information to help others
to judge the value of your contribution;
not just the information that leads to judgment
in one particular direction or another.    Richard Feynman

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5